PharmacyCodes



Nebramycin en es it fr

Nebramycin Brand names, Nebramycin Analogs

Nebramycin Brand Names Mixture

  • No information avaliable

Nebramycin Chemical_Formula

C18H36N4O11

Nebramycin RX_link

http://www.rxlist.com/cgi/generic3/kanamycin.htm

Nebramycin fda sheet

Nebramycin msds (material safety sheet)

Nebramycin MSDS

Nebramycin Synthesis Reference

No information avaliable

Nebramycin Molecular Weight

484.499 g/mol

Nebramycin Melting Point

No information avaliable

Nebramycin H2O Solubility

No information avaliable

Nebramycin State

Solid

Nebramycin LogP

-7.936

Nebramycin Dosage Forms

No information avaliable

Nebramycin Indication

For treatment of infections where one or more of the following are the known or suspected pathogens: E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species.

Nebramycin Pharmacology

Kanamycin is an aminoglycoside antibiotic. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth. Aminoglycosides are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, but other types of antibiotics are more potent and less damaging to the host. In the past the aminoglycosides have been used in conjunction with penicillin-related antibiotics in streptococcal infections for their synergistic effects, particularly in endocarditis. Aminoglycosides are mostly ineffective against anaerobic bacteria, fungi and viruses.

Nebramycin Absorption

No information avaliable

Nebramycin side effects and Toxicity

LD 50 - ORAL, MOUSE = 17500 MG/KG, LD 50 - ORAL, RAT = >4 GM/KG, LD 50 - ORAL, RABBIT = >3 GM/KG

Nebramycin Patient Information

No information avaliable

Nebramycin Organisms Affected

Enteric bacteria and other eubacteria